Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 10 studies | 31% ± 17% | |
endothelial cell | 8 studies | 23% ± 7% | |
oligodendrocyte | 7 studies | 26% ± 7% | |
microglial cell | 6 studies | 24% ± 6% | |
type II pneumocyte | 5 studies | 19% ± 5% | |
macrophage | 5 studies | 27% ± 10% | |
type I pneumocyte | 5 studies | 32% ± 7% | |
myeloid cell | 4 studies | 18% ± 1% | |
epithelial cell | 4 studies | 34% ± 2% | |
fibroblast | 4 studies | 17% ± 1% | |
glutamatergic neuron | 4 studies | 51% ± 19% | |
oligodendrocyte precursor cell | 4 studies | 28% ± 7% | |
classical monocyte | 3 studies | 22% ± 2% | |
CD8-positive, alpha-beta T cell | 3 studies | 16% ± 1% | |
hepatocyte | 3 studies | 29% ± 12% | |
GABAergic neuron | 3 studies | 48% ± 3% | |
club cell | 3 studies | 24% ± 9% | |
monocyte | 3 studies | 19% ± 2% | |
neuron | 3 studies | 25% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 715.21 | 1445 / 1445 | 100% | 15.20 | 183 / 183 |
ovary | 100% | 873.18 | 180 / 180 | 100% | 13.09 | 430 / 430 |
pancreas | 100% | 810.84 | 328 / 328 | 100% | 14.34 | 178 / 178 |
prostate | 100% | 773.51 | 245 / 245 | 100% | 17.95 | 502 / 502 |
lung | 100% | 965.38 | 578 / 578 | 100% | 16.56 | 1154 / 1155 |
breast | 100% | 876.19 | 459 / 459 | 100% | 16.75 | 1116 / 1118 |
liver | 100% | 560.86 | 226 / 226 | 100% | 14.53 | 405 / 406 |
thymus | 100% | 820.83 | 653 / 653 | 100% | 18.60 | 603 / 605 |
stomach | 100% | 741.79 | 359 / 359 | 100% | 15.76 | 285 / 286 |
bladder | 100% | 912.81 | 21 / 21 | 100% | 14.26 | 502 / 504 |
uterus | 100% | 772.05 | 170 / 170 | 100% | 11.36 | 457 / 459 |
kidney | 100% | 869.25 | 89 / 89 | 100% | 17.22 | 897 / 901 |
intestine | 100% | 797.40 | 966 / 966 | 99% | 17.59 | 524 / 527 |
brain | 99% | 504.68 | 2614 / 2642 | 100% | 14.83 | 705 / 705 |
adrenal gland | 100% | 791.09 | 258 / 258 | 95% | 10.40 | 219 / 230 |
skin | 100% | 1021.29 | 1808 / 1809 | 94% | 14.47 | 446 / 472 |
blood vessel | 100% | 988.50 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 16.20 | 29 / 29 |
spleen | 100% | 611.52 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 10.49 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.97 | 1 / 1 |
adipose | 100% | 902.96 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 99% | 450.76 | 797 / 803 | 0% | 0 | 0 / 0 |
heart | 95% | 479.32 | 818 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 10.65 | 74 / 80 |
peripheral blood | 92% | 810.54 | 858 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_2000772 | Biological process | regulation of cellular senescence |
GO_0070301 | Biological process | cellular response to hydrogen peroxide |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | ZNF277 |
Protein name | Uncharacterized protein ZNF277 Zinc finger protein 277 (Nuclear receptor-interacting factor 4) Zinc finger protein (C2H2 type) 277 ZNF277 protein Zinc finger protein 277 |
Synonyms | hCG_14753 ZNF277P tcag7.77 NRIF4 |
Description | FUNCTION: Probable transcription factor. Involved in modulation of cellular senescence; represses transcription of the tumor suppressor gene INK4A/ARF, perhaps acting via the Polycomb group (PcG) complex PRC1. . |
Accessions | ENST00000361822.8 ENST00000421864.2 H7C460 A4D0S7 Q75MZ1 E7EW13 ENST00000425229.5 Q8WWA6 F8WBE4 Q9NRM2 C9JH62 ENST00000450657.1 ENST00000361946.8 C9J3B6 ENST00000457808.5 G5E9M4 ENST00000421043.5 |